COMP <GO>
TLSI vs KEQU // EV/EBITDA & P/E VALUATION
TriSalus Life Sciences Inc. (NASDAQ) VS. Kewaunee Scientific Corporation (NASDAQ) • 15-METRIC TALLY: TLSI 3
— KEQU 6
■ METRIC PARITY
LAST: $3.86 (-1.78%) • MKT CAP: $237.7M
valuation
—
LAST: $33.51 (-3.48%) • MKT CAP: $97.0M
valuation
6.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TLSI VS. KEQU)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TLSI | KEQU | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 84.60% | 28.50% | +56.10 | TLSI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 16.70% | -51.70 | KEQU | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 6.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.96% | 19.20% | -27.16 | KEQU | /fcf-yield <GO> |
| Operating Margin | -59.70% | 5.90% | -65.60 | KEQU | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 3.40% | -63.40 | KEQU | /net-margins <GO> |
| Revenue Growth (YoY) | 53.40% | 17.30% | +36.10 | TLSI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.37 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | KEQU | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.9 | 49.8 | -4.90 | KEQU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 8.5x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $237.7M | $97.0M | $140.7M | TLSI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TLSI REV | KEQU REV | TLSI GROSS % | KEQU GROSS % | TLSI FCF | KEQU FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $45.2M | $282.0M | 84.6% | 28.5% | -$18.9M | $18.6M |
| FY 2024 | $29.4M | $240.5M | 86.1% | 28.6% | -$41.2M | $14.8M |
| FY 2023 | $18.5M | $203.8M | — | — | -$50.6M | $19.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TLSI // BETA —
KEQU // BETA —